Laureate Pharma Information

On January 31, 2011 we changed our name to Laureate Biopharmaceutical Services, Inc. For all current connections please see the LinkedIn page for Laureate Biopharmaceutical Services, Inc. We are a full-service biopharmaceutical contract development and manufacturing organization. Laureate’s scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins. In addition, the company’s portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate has served a global client base from its Princeton, New Jersey facility since 1981 and is a portfolio company of Saints Capital, LLC.